Literature DB >> 6372563

Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia.

V J Dzau, N K Hollenberg.   

Abstract

To assess the effect of furosemide and captopril on renal function and hyponatremia in patients with severe heart failure, we studied two groups of patients with hyponatremia who were receiving digoxin therapy and whose sodium intake was 40 meq/d. One group received captopril and furosemide, the second received captopril. The first group responded to combination therapy with a brisk natriuresis and diuresis, weight reduction, and an increase in serum sodium concentration. Patients who received captopril alone did not respond, despite a similar increase in renal plasma flow and glomerular filtration rate. When furosemide was then administered to patients who had received captopril alone, a brisk natriuresis, weight loss, and correction of hyponatremia followed. Treatment with furosemide is necessary to promote natriuresis and correction of hyponatremia in patients with severe heart failure treated with captopril; the renal vascular action of captopril enhances the effectiveness of furosemide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372563     DOI: 10.7326/0003-4819-100-6-777

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

Review 1.  ACE inhibitors and the kidney. A risk-benefit assessment.

Authors:  G Navis; H J Faber; D de Zeeuw; P E de Jong
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 2.  Clinical pharmacokinetics in heart failure. An updated review.

Authors:  F V Shammas; K Dickstein
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

Review 3.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

4.  A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.

Authors:  M J Jamieson; J Webster; G Fowler; J Rawles; F W Smith; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

Review 5.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

6.  Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function.

Authors:  S Ljungman; J H Laragh; R J Cody
Journal:  Drugs       Date:  1990       Impact factor: 9.546

7.  The renin angiotensin aldosterone system and frusemide response in congestive heart failure.

Authors:  S Reed; P Greene; T Ryan; B Cerimele; U Schwertschlag; M Weinberger; J Voelker
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

8.  Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study.

Authors:  B Herrlin; O Nyquist; C Sylvén
Journal:  Br Heart J       Date:  1991-09

9.  Sodium and water balance in chronic congestive heart failure.

Authors:  R J Cody; A B Covit; G L Schaer; J H Laragh; J E Sealey; J Feldschuh
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

10.  Nutrient intake in heart failure patients.

Authors:  Daurice A Grossniklaus; Marian C O'Brien; Patricia C Clark; Sandra B Dunbar
Journal:  J Cardiovasc Nurs       Date:  2008 Jul-Aug       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.